551 related articles for article (PubMed ID: 28748479)
1. STING Signaling in Cancer Cells: Important or Not?
Sokolowska O; Nowis D
Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):125-132. PubMed ID: 28748479
[TBL] [Abstract][Full Text] [Related]
2. Agonist of stimulator of interferon genes as antitumor agents: a patent review (2008-2020).
Chen NN; Zhang H; You QD; Xu XL
Expert Opin Ther Pat; 2021 Jun; 31(6):563-584. PubMed ID: 33459063
[TBL] [Abstract][Full Text] [Related]
3. cGAS-STING signaling in cancer immunity and immunotherapy.
Du H; Xu T; Cui M
Biomed Pharmacother; 2021 Jan; 133():110972. PubMed ID: 33254021
[TBL] [Abstract][Full Text] [Related]
4. Molecular Pathways: Targeting the Stimulator of Interferon Genes (STING) in the Immunotherapy of Cancer.
Corrales L; Gajewski TF
Clin Cancer Res; 2015 Nov; 21(21):4774-9. PubMed ID: 26373573
[TBL] [Abstract][Full Text] [Related]
5. Novel chemical compound SINCRO with dual function in STING-type I interferon and tumor cell death pathways.
Kimura Y; Negishi H; Matsuda A; Endo N; Hangai S; Inoue A; Nishio J; Taniguchi T; Yanai H
Cancer Sci; 2018 Sep; 109(9):2687-2696. PubMed ID: 29981256
[TBL] [Abstract][Full Text] [Related]
6. Targeting Cytosolic Nucleic Acid-Sensing Pathways for Cancer Immunotherapies.
Iurescia S; Fioretti D; Rinaldi M
Front Immunol; 2018; 9():711. PubMed ID: 29686682
[TBL] [Abstract][Full Text] [Related]
7. Rationale for stimulator of interferon genes-targeted cancer immunotherapy.
Rivera Vargas T; Benoit-Lizon I; Apetoh L
Eur J Cancer; 2017 Apr; 75():86-97. PubMed ID: 28219022
[TBL] [Abstract][Full Text] [Related]
8. STING pathway agonism as a cancer therapeutic.
Flood BA; Higgs EF; Li S; Luke JJ; Gajewski TF
Immunol Rev; 2019 Jul; 290(1):24-38. PubMed ID: 31355488
[TBL] [Abstract][Full Text] [Related]
9. cGAS/STING Pathway in Cancer: Jekyll and Hyde Story of Cancer Immune Response.
Bose D
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156566
[TBL] [Abstract][Full Text] [Related]
10. STING Activation and its Application in Immuno-Oncology.
Lian Y; Duffy KJ; Yang J
Curr Top Med Chem; 2019; 19(24):2205-2227. PubMed ID: 31642767
[TBL] [Abstract][Full Text] [Related]
11. Nucleic Acid Sensing Machinery: Targeting Innate Immune System for Cancer Therapy.
Iurescia S; Fioretti D; Rinaldi M
Recent Pat Anticancer Drug Discov; 2018; 13(1):2-17. PubMed ID: 29086701
[TBL] [Abstract][Full Text] [Related]
12. No Longer A One-Trick Pony: STING Signaling Activity Beyond Interferon.
Wu J; Yan N
J Mol Biol; 2022 Mar; 434(6):167257. PubMed ID: 34627792
[TBL] [Abstract][Full Text] [Related]
13. STING-mediated DNA sensing in cancer immunotherapy.
Zhou X; Jiang Z
Sci China Life Sci; 2017 Jun; 60(6):563-574. PubMed ID: 28639100
[TBL] [Abstract][Full Text] [Related]
14. Insight into the dichotomous regulation of STING activation in immunotherapy.
Hu Z; Yang Y; Fang L; Zhou J; Zhang H
Immunopharmacol Immunotoxicol; 2021 Apr; 43(2):126-137. PubMed ID: 33618600
[TBL] [Abstract][Full Text] [Related]
15. STING: a master regulator in the cancer-immunity cycle.
Zhu Y; An X; Zhang X; Qiao Y; Zheng T; Li X
Mol Cancer; 2019 Nov; 18(1):152. PubMed ID: 31679519
[TBL] [Abstract][Full Text] [Related]
16. Positive feedback regulation of type I interferon by the interferon-stimulated gene STING.
Ma F; Li B; Yu Y; Iyer SS; Sun M; Cheng G
EMBO Rep; 2015 Feb; 16(2):202-12. PubMed ID: 25572843
[TBL] [Abstract][Full Text] [Related]
17. STING activation in cancer immunotherapy.
Su T; Zhang Y; Valerie K; Wang XY; Lin S; Zhu G
Theranostics; 2019; 9(25):7759-7771. PubMed ID: 31695799
[TBL] [Abstract][Full Text] [Related]
18. STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade.
Yang H; Lee WS; Kong SJ; Kim CG; Kim JH; Chang SK; Kim S; Kim G; Chon HJ; Kim C
J Clin Invest; 2019 Jul; 129(10):4350-4364. PubMed ID: 31343989
[TBL] [Abstract][Full Text] [Related]
19. STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity.
Demaria O; De Gassart A; Coso S; Gestermann N; Di Domizio J; Flatz L; Gaide O; Michielin O; Hwu P; Petrova TV; Martinon F; Modlin RL; Speiser DE; Gilliet M
Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15408-13. PubMed ID: 26607445
[TBL] [Abstract][Full Text] [Related]
20. cGAS-STING and Cancer: Dichotomous Roles in Tumor Immunity and Development.
Ng KW; Marshall EA; Bell JC; Lam WL
Trends Immunol; 2018 Jan; 39(1):44-54. PubMed ID: 28830732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
